Our in vivo CD4 imaging in the presence of ATA is consistent with tumor studies in patients which showed that these immune complexes are cleared rapidly by the liver resulting in high hepatic uptake, altered blood clearance, and reduced target uptake of the radiotracer[42, 43]. Here, CD4 is linked to neoplasm.